Predictive proteomic signatures for response of pancreatic cancer patients receiving chemotherapy

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer that is characterized by its poor prognosis, rapid progression and development of drug resistance. Chemotherapy is a vital treatment option for most of PDAC patients. Stratification of PDAC patients, who would have a higher likel...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Hong, Chen, Ru, Brentnall, Teresa A., Eng, Jimmy K., Picozzi, Vincent J., Pan, Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636003/
https://www.ncbi.nlm.nih.gov/pubmed/31346328
http://dx.doi.org/10.1186/s12014-019-9251-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636003/
https://www.ncbi.nlm.nih.gov/pubmed/31346328
http://dx.doi.org/10.1186/s12014-019-9251-3

Ejemplares similares